Description: Recombinant Human Thrombopoietin receptor(MPL),partial expressed in E.coli

Description: A polyclonal antibody against MPL. Recognizes MPL from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Description: A polyclonal antibody against MPL. Recognizes MPL from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Description: A polyclonal antibody against MPL. Recognizes MPL from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Description: Recombinant Human Thrombopoietin receptor(MPL),partial expressed in Yeast

Description: A Monoclonal antibody against Human MPL. The antibodies are raised in Mouse and are from clone 1H2. This antibody is applicable in WB, FC, E

Description: Description of target: In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.113 ng/mL

Description: Description of target: The thrombopoietin receptor (TPOR), also known as CD110, is a protein that in humans is encoded by the MPL (myeloproliferative leukemia virus) oncogene. The human MPL gene is mapped to chromosome 1p34. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs. TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <15pg/ml

Description: Description of target: Receptor for thrombopoietin. May represent a regulatory molecule specific for TPO-R-dependent immune responses. ;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.469 ng/mL

Description: Description of target: Receptor for thrombopoietin. May represent a regulatory molecule specific for TPO-R-dependent immune responses.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.113ng/mL